← Eichor
Condition: Tace Transcatheter Arterial Chemoembolization Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tace Transcatheter Arterial Chemoembolization

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
NA · 1 location(s) · Taichung Tzu Chi Hospital · NCT07178093TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
NA · 1 location(s) · Sun Yat-sen University · NCT06740370A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepato
Phase N/A · 1 location(s) · Zhongda Hospital · NCT07351669TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
NA · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06487663Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)
Phase N/A · 6 location(s) · Fujian Provincial Hospital · NCT06602011TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma
Phase 2 · 1 location(s) · Fudan University · NCT04954781Comparison of Efficacy in SBRT of Large HCC With or Without TACE
Phase N/A · 1 location(s) · Beijing 302 Hospital · NCT04512846TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT
NA · 1 location(s) · Third Affiliated Hospital, Sun Yat-Sen University · NCT05984511TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.
Phase N/A · 1 location(s) · Zhongda Hospital · NCT06669377Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)
Phase N/A · 4 location(s) · Fujian Provincial Hospital · NCT06561399H101 Plus TACE for r/m HNSCC
Phase 2 · 1 location(s) · West China Hospital · NCT07398664TACE Combined Surgery for the Resectable Huge HCC
Phase N/A · 1 location(s) · Sun Yat-sen University · NCT06898398Lenvatinib Combined With TACE and Camrelizumab in Conversion Resection for Advanced Hepatocellular Carcinoma (LEN-TAC St
Phase 3 · 1 location(s) · Wen Tianfu · NCT05738616
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.